Unknown

Dataset Information

0

ARNT as a Novel Antifibrotic Target in CKD.

ABSTRACT:

SUBMITTER: Haase VH 

PROVIDER: S-EPMC6348016 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

ARNT as a Novel Antifibrotic Target in CKD.

Haase Volker H VH  

American journal of kidney diseases : the official journal of the National Kidney Foundation 20181018 2

Similar Datasets

Unknown Multifunctional Natural Polymer Nanoparticles as Antifibrotic Gene Carriers for CKD Therapy.
| S-EPMC7609017 | biostudies-literature
Unknown Tamoxifen associated to the conservative CKD treatment promoted additional antifibrotic effects on experimental hypertensive nephrosclerosis.
| S-EPMC10460450 | biostudies-literature
Unknown Identification of ARNT-regulated BIRC3 as the target factor in cadmium renal toxicity.
| S-EPMC5725491 | biostudies-literature
Unknown Indoleamine 2,3-dioxygenase-1, a Novel Therapeutic Target for Post-Vascular Injury Thrombosis in CKD.
| S-EPMC8806102 | biostudies-literature
Unknown Spontaneous Lung Fibrosis Resolution Reveals Novel Antifibrotic Regulators.
| S-EPMC8008802 | biostudies-literature
Unknown Glaucoma: Novel antifibrotic therapeutics for the trabecular meshwork.
| S-EPMC10804937 | biostudies-literature
Unknown A novel colistin adjuvant identified by virtual screening for ArnT inhibitors.
| S-EPMC7443731 | biostudies-literature
Unknown Secreted Frizzled-related protein 2 as a target in antifibrotic therapeutic intervention.
| S-EPMC3948976 | biostudies-literature
Unknown Glomerular hyperfiltration as a therapeutic target for CKD.
| S-EPMC12086678 | biostudies-literature
Unknown Omega 3 Fatty Acids Attenuate the Acute Kidney Injury to CKD Transition and Renal Fibrosis: Identification of Antifibrotic Metabolites.
| S-EPMC11556936 | biostudies-literature